Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

作者： Mafficini A , Lawlor Rt , Luchini C , Jiménez-Vacas Jm , Ibáñez-Costa A

DOI: 10.21203/RS.3.RS-527836/V1

关键词: Cancer stem cell 、 Drug 、 Splicing factor 、 Cancer research 、 Pancreatic cancer 、 Biology 、 Vulnerability 、 DUAL (cognitive architecture) 、 Text mining 、 RNA splicing